S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7230 −0.30%
CLOSED · 17:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
SM
INSIDER · PTCT · PTC THERAPEUTICS, INC. · DIRECTOR

SCHMERTZLER MICHAEL

Every open-market transaction filed under this name, Aug 19 to Aug 27.

Filings
9
0 buys · 9 sells
Bought
open market, at cost
Sold
$3.6M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 27PTCTPTC THERAPEUTICS, INC.DirectorSell610$72.22$44K−2.3%
Aug 27PTCTPTC THERAPEUTICS, INC.DirectorSell11,890$71.55$851K−1.4%
Aug 26PTCTPTC THERAPEUTICS, INC.DirectorSell5,626$73.18$412K−3.6%
Aug 26PTCTPTC THERAPEUTICS, INC.DirectorSell6,874$72.74$500K−3.0%
Aug 20PTCTPTC THERAPEUTICS, INC.DirectorSell691$72.92$50K−3.2%
Aug 20PTCTPTC THERAPEUTICS, INC.DirectorSell2,390$71.88$172K−1.8%
Aug 20PTCTPTC THERAPEUTICS, INC.DirectorSell9,419$70.78$667K−0.3%
Aug 19PTCTPTC THERAPEUTICS, INC.DirectorSell7,165$73.67$528K−4.2%
Aug 19PTCTPTC THERAPEUTICS, INC.DirectorSell5,335$72.86$389K−3.2%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.